Key result
A 40-year-old female with cardiac sarcoidosis-induced heart failure was managed with optimization of medical therapy, immunosuppression, and placement of a biventricular ICD.
Why the study?
Cardiac sarcoidosis must be diagnosed early and treated aggressively when young patients present with acute heart failure, conduction abnormalities, or new arrhythmia.
Case Report (n=1)
Cardiac sarcoidosis should be considered in young, otherwise healthy patients presenting with new-onset non-ischemic cardiomyopathy and heart failure, requiring aggressive medical therapy and potential ICD placement.
Cardiac sarcoidosis merits consideration in young patients with new HF; leaves open optimal diagnostic and treatment strategies pending prospective data.
Sarcoidosis is a common disease with the incidence of cardiac involvement varying. Cardiac sarcoidosis should be kept on the differential when young patients present with acute heart failure, conduction abnormalities or new arrhythmia. Cardiac involvement in sarcoidosis must be diagnosed early and treated aggressively. Here we present a patient who presented with shortness of breath and was found to have significant heart failure with reduced ejection fraction caused by sarcoidosis with cardiac involvement. She was treated with optimization of medical therapy for heart failure and eventually required implantable cardioverter defibrillator (ICD) placement.
No takes yet. Share an insight, caveat, or question.
Figart et al. (2021) conducted a case report in Cardiac sarcoidosis-induced heart failure (n=1). Medical therapy and biventricular ICD was evaluated. A 40-year-old female with cardiac sarcoidosis-induced heart failure was managed with optimization of medical therapy, immunosuppression, and placement of a biventricular ICD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: